Evidence map›Paper›PMID 25085254›Full record

ReviewInternational journal of hematology2014

Ikaros fingers on lymphocyte differentiation.

Toshimi Yoshida, Katia Georgopoulos

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of hematology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A new pipeline SPICE identifies novel JUN-IKZF1 composite elements.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Mycovirus-ContainingInternational journal of molecular sciences · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Dominant negative variants inJournal of medical genetics · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Toshimi YoshidaCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Bldg.149-3, 13th st, Charlestown, MA, 02129, USA, toshimi.yoshida@cbrc2.mgh.harvard.edu.
Katia Georgopoulos
Harvard University · USMassachusetts General Hospital · US

Funding

Ikaros regulation: study on hemo-lymphopoiesisR01CA162092 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI GEORGOPOULOS, KATIA · 2011 to 2015
$1.8M
NCI NIH HHS R01 CA162092
6 · The paper itself

Abstract

The Ikaros family of DNA-binding proteins are critical regulators of lymphocyte differentiation. In multipotent, hematopoietic progenitors, Ikaros supports transcriptional priming of genes promoting lymphocyte differentiation. Ikaros targets the Nucleosome Remodeling Deacetylase (NuRD) complex to lymphoid lineage genes, thereby increasing chromatin accessibility and transcriptional priming. After lymphoid lineage specification, Ikaros expression is raised to levels characteristic of intermediate B cell and T cell precursors, which is necessary to support maturation and prevent leukemogenesis. Loss of Ikaros in T cell precursors allows the NuRD complex to repress lymphocyte genes and extends its targeting to genes that support growth and proliferation, causing their activation and triggering a cascade of events that leads to leukemogenesis. Loss of Ikaros in B cell precursors blocks differentiation and perpetuates stromal adhesion by enhancing integrin signaling. The combination of integrin and cytokine signaling in Ikaros-deficient pre-B cells promotes their survival and self-renewal. The stages of lymphocyte differentiation that are highly dependent on Ikaros are underscored by changes in Ikaros transcription, supported by a complex network of stage-specific regulatory networks that converge upon the Ikzf1 locus. It is increasingly apparent that understanding the regulatory networks that operate upstream and downstream of Ikaros is critical not only for our understanding of normal lymphopoiesis, but also in placing the right finger on the mechanisms that support hematopoietic malignancies in mouse and human.

Indexed as

AnimalsAutoantigensCell DifferentiationCell LineageEpigenesis, GeneticHematopoietic Stem CellsHumansIkaros Transcription FactorLymphopoiesisMi-2 Nucleosome Remodeling and Deacetylase ComplexMicePrecursor Cells, B-LymphoidPrecursor Cells, T-LymphoidProtein IsoformsSignal TransductionAutoantigensCHD4 protein, humanIkaros Transcription FactorIKZF1 protein, humanMi-2 Nucleosome Remodeling and Deacetylase ComplexProtein Isoforms

Identifiers

PMID25085254
PMCPMC4492456
OpenAlexW2017165266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.